Status:

COMPLETED

Platelet-rich Plasma for Stress Urinary Incontinence

Lead Sponsor:

Kaohsiung Medical University Chung-Ho Memorial Hospital

Conditions:

Stress Urinary Incontinence

Eligibility:

FEMALE

20-85 years

Phase:

NA

Brief Summary

Stress urinary incontinence (SUI) is defined by the International Continence Society (ICS) as "the complaint of any involuntary loss of urine on effort or physical exertion or on sneezing or coughing....

Detailed Description

Women with SUI were enrolled. Pre-treatment evaluation included Overactive Bladder Symptom Score (OABSS), International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ...

Eligibility Criteria

Inclusion

  • Women with SUI
  • Age between 20 to 85 years

Exclusion

  • Under anti-platelet agent treatment
  • Under NSAIDs
  • Platelet dysfunction syndrome
  • Critical thrombocytopenia
  • Hypofibrionogenaemia
  • Sepsis
  • Acute and chronic infections
  • Chronic liver disease
  • Anti-coagulation therapy
  • History of malignancy
  • Pregnancy

Key Trial Info

Start Date :

June 29 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 3 2018

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04279210

Start Date

June 29 2017

End Date

October 3 2018

Last Update

February 24 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Taiwan, 807

Platelet-rich Plasma for Stress Urinary Incontinence | DecenTrialz